Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2020-04-29 Interim / Quarterly Rep…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
First quarter result for 2020 for Medistim ASA
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first quarter of 2020, titled '1st quarter report and financials for 2020'. It contains detailed financial statements, management commentary on operational status, geographic performance, and market trends, adhering to IFRS and IAS 34 standards. It is not an announcement of a report, but the report itself. Q1 2020
2020-04-29 English
First quarter result for 2020 for Medistim ASA
Investor Presentation Classification · 99% confidence The document is titled "Medistim ASA First quarter 2020" and contains detailed financial statements for Q1 2020, including a Profit and Loss statement, Balance Sheet, and segment updates. It explicitly covers performance for a period shorter than a year (Q1). This structure and content strongly indicate a comprehensive quarterly financial report. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it contains full financial statements, not just highlights. It is also not a Call Transcript (CT) or an Investor Presentation (IP), although it has presentation elements, the core is the financial reporting.
2020-04-29 English
First quarter result for 2020 for Medistim ASA
Earnings Release Classification · 100% confidence The document explicitly states it contains the "First quarter result for 2020 for Medistim ASA." It provides key financial highlights for the period (Sales, Operating Profit, Cash position) but is very brief (779 characters). This structure—a short announcement detailing key performance indicators for a specific interim period—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like IR or 10-K) nor is it merely an announcement *about* a report (RPA/RNS). The mention of the dividend authorization from the General Meeting is secondary to the primary focus on quarterly financial performance. Q1 2020
2020-04-29 English
Protocol from General Meeting in Medistim ASA
AGM Information Classification · 99% confidence The document is explicitly titled "MINUTES FROM THE GENERAL MEETING IN MEDISTIM ASA" and details the proceedings, agenda items, and voting results of a meeting held on April 28th, 2020. Key sections cover the approval of the annual report, allocation of profit, remuneration declaration, election of board members, and authorizations for capital changes. These minutes document the formal decisions and outcomes of a shareholder meeting. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it contains elements that might be found in other reports (like remuneration details), the primary nature of the document is the record of the meeting itself.
2020-04-28 English
Protocol from General Meeting in Medistim ASA
AGM Information Classification · 95% confidence The document text is extremely short (164 characters) and explicitly states: "Attached is the protocol from the General Meeting in Medistim ASA." A 'protocol' from a General Meeting is essentially the official minutes or record of the proceedings. Since this document is merely announcing the availability of the protocol (the 'attachment') rather than containing the full content of the AGM proceedings or voting results, it fits best under the category for announcing the publication of a report or document. Given the context of an AGM protocol, 'AGM-R' (AGM Information) is the most specific fit for the content being announced, but based on the 'MENU VS MEAL' rule, if this is just an announcement of the protocol, 'RPA' (Report Publication Announcement) is a strong candidate. However, since the content *is* the AGM protocol itself, and AGM-R covers 'Presentations and materials shared during the Annual General Meeting (AGM)', classifying the protocol itself as AGM-R is more accurate than classifying the announcement of the protocol as RPA, especially since the text is the title/header of the protocol itself. Given the brevity and the direct reference to the General Meeting, AGM-R is the primary classification for the material itself.
2020-04-28 English
Disclosure of voting rights in Medistim ASA
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly discusses the authorization of voting shares for the Chairman of Medistim ASA in connection with the Annual General Meeting (AGM) held on April 28, 2020. It details the total number of voting shares controlled by an individual (Øyvin Brøymer) and the resulting percentage of total voting shares. This content directly relates to the voting structure and results/authorizations pertaining to a general meeting, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA) category, as it is a disclosure of voting rights/authorizations for the AGM.
2020-04-27 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.